A detailed history of Anchor Investment Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Anchor Investment Management, LLC holds 6,039 shares of DHR stock, worth $1.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,039
Previous 5,961 1.31%
Holding current value
$1.4 Million
Previous $1.49 Billion 12.73%
% of portfolio
0.16%
Previous 0.15%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

BUY
$239.25 - $280.76 $18,661 - $21,899
78 Added 1.31%
6,039 $1.68 Billion
Q2 2024

Sep 20, 2024

SELL
$235.51 - $267.98 $41,920 - $47,700
-178 Reduced 2.9%
5,961 $1.49 Billion
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $402,896 - $459,604
-1,794 Reduced 22.61%
6,139 $1.53 Billion
Q4 2023

Jan 02, 2024

BUY
$185.1 - $233.13 $1.47 Million - $1.85 Million
7,933 New
7,933 $1.84 Billion
Q3 2023

Jan 02, 2024

SELL
$233.08 - $265.59 $12,586 - $14,341
-54 Reduced 0.73%
7,303 $1.81 Billion
Q2 2023

Jan 02, 2024

BUY
$224.99 - $256.14 $52,647 - $59,936
234 Added 3.29%
7,357 $1.77 Billion
Q1 2023

Jan 02, 2024

BUY
$239.75 - $277.0 $10,069 - $11,634
42 Added 0.59%
7,123 $1.8 Billion
Q4 2022

Jan 02, 2024

SELL
$241.42 - $282.29 $205,689 - $240,511
-852 Reduced 10.74%
7,081 $1.88 Billion
Q3 2022

Jan 02, 2024

SELL
$247.06 - $1507.4 $135,141 - $824,547
-547 Reduced 6.9%
7,386 $1.91 Billion
Q2 2022

Jan 02, 2024

SELL
$237.11 - $299.66 $48,844 - $61,729
-206 Reduced 2.74%
7,310 $1.85 Billion
Q1 2022

Jan 02, 2024

SELL
$257.27 - $315.76 $4,116 - $5,052
-16 Reduced 0.21%
7,516 $2.2 Billion
Q4 2021

Jan 02, 2024

SELL
$292.08 - $329.01 $25,703 - $28,952
-88 Reduced 1.15%
7,532 $2.48 Billion
Q3 2021

Jan 02, 2024

SELL
$272.21 - $332.43 $85,201 - $104,050
-313 Reduced 3.95%
7,620 $2.32 Billion
Q2 2021

Jan 02, 2024

BUY
$225.08 - $271.69 $8,778 - $10,595
39 Added 0.49%
8,006 $2.15 Billion
Q1 2021

Jan 02, 2024

BUY
$212.38 - $245.9 $285,013 - $329,997
1,342 Added 20.26%
7,967 $1.79 Billion
Q4 2020

Jan 02, 2024

BUY
$212.5 - $245.46 $39,100 - $45,164
184 Added 2.86%
6,625 $1.47 Billion
Q3 2020

Jan 02, 2024

SELL
$177.16 - $215.33 $264,322 - $321,272
-1,492 Reduced 18.81%
6,441 $1.39 Billion
Q2 2020

Jan 02, 2024

SELL
$128.7 - $176.83 $19,948 - $27,408
-155 Reduced 2.36%
6,413 $1.13 Billion
Q1 2020

Jan 02, 2024

SELL
$121.39 - $169.05 $16,994 - $23,667
-140 Reduced 2.09%
6,568 $909 Million
Q4 2019

Jan 02, 2024

SELL
$133.47 - $153.48 $15,349 - $17,650
-115 Reduced 1.69%
6,708 $1.03 Billion
Q3 2019

Jan 02, 2024

SELL
$135.4 - $146.47 $150,294 - $162,581
-1,110 Reduced 13.99%
6,823 $985 Million
Q2 2019

Jan 02, 2024

BUY
$124.88 - $143.73 $11,863 - $13,654
95 Added 1.36%
7,068 $1.01 Billion
Q1 2019

Jan 02, 2024

BUY
$97.62 - $132.29 $8,785 - $11,906
90 Added 1.31%
6,973 $921 Million
Q4 2018

Jan 02, 2024

BUY
$94.85 - $109.54 $9,485 - $10,954
100 Added 1.47%
6,883 $710 Million
Q3 2018

Jan 02, 2024

SELL
$98.13 - $108.9 $112,849 - $125,235
-1,150 Reduced 14.5%
6,783 $737 Million
Q2 2018

Jan 03, 2024

SELL
$96.1 - $103.24 $108,112 - $116,145
-1,125 Reduced 14.18%
6,808 $672 Million
Q1 2018

Jan 03, 2024

BUY
$92.16 - $103.8 $5,529 - $6,228
60 Added 0.91%
6,633 $649 Million
Q4 2017

Jan 03, 2024

BUY
$85.26 - $94.62 $25,833 - $28,669
303 Added 4.83%
6,573 $610 Million
Q3 2017

Jan 03, 2024

BUY
$79.29 - $88.45 $10,704 - $11,940
135 Added 2.2%
6,270 $538 Million
Q2 2017

Jan 03, 2024

SELL
N/A
-1,798 Reduced 22.66%
6,135 $518 Million
Q1 2017

Jan 03, 2024

SELL
N/A
-314 Reduced 4.87%
6,135 $525 Million
Q4 2016

Jan 03, 2024

SELL
N/A
-50 Reduced 0.77%
6,449 $502 Million
Q3 2016

Jan 03, 2024

SELL
N/A
-15 Reduced 0.23%
6,499 $509 Million
Q2 2016

Jan 03, 2024

SELL
N/A
-1,419 Reduced 17.89%
6,514 $658 Million
Q1 2016

Jan 03, 2024

SELL
N/A
-1,354
6,579 $624 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.